Page 6 - Drayson Phd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Drayson phd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Drayson Phd Today - Breaking & Trending Today

Investegate |Sensyne Health PLC Announcements | Sensyne Health PLC: Management appointments

Oxford, U.K. 5 February 2021
: Sensyne Health plc (LSE: SENS) ( Sensyne or the Company or the Group ), the UK Clinical AI company, announces that it has appointed Hina Zaman as Managing Director of its Healthcare Division and Martin Gouldstone as Chief Business Officer of its Life Sciences Division.
Hina Zaman joins Sensyne from Babylon Health, where as Product Director she led the company s global product for value-based care and previously its global product proposition in the women s health space. Prior to that, Hina founded the UK s first virtual care platform for women s health, pioneering a new model of personalised, proactive care for health consumers. Hina has extensive experience as a healthcare management consultant, leading change initiatives across the NHS commissioning and provider landscape while at Finnamore Ltd. (now part of GE Healthcare), and in US healthcare systems while at Deloitte ....

United Kingdom , City Of , Michael Norris , Richard Pye , Martin Gouldstone , Mary Jane Elliott , Sukaina Virji , Freng Fmedsci , Healthcare Division , Life Sciences Division , Capital Solutions At Syneos , Market Of The London Stock Exchange , Babylon Health , Sensyne Health , Finnamore Ltd , Head Of Life Sciences , Life Sciences At Sensyne , Ge Healthcare , Consilium Strategic Communications , United Kingdom Clinical , Hina Zaman , Managing Director , Chief Business Officer , Life Sciences , Product Director , Syneos One ,

Investegate |Sensyne Health PLC Announcements | Sensyne Health PLC: Sensyne Health Interim Results

Oxford, UK; 21 January 2021:
Sensyne Health plc (LSE: SENS) ( Sensyne or the Company or the Group ), the UK Clinical AI company, today announces its Interim Results for the six months ended 31 October 2020.

I am pleased to report that Sensyne has made significant commercial progress over the past six months and has achieved several key milestones in the development of its research partnerships with NHS Trusts and in its work for leading pharmaceutical companies applying Clinical AI to improve patient care and accelerate life sciences research. I am particularly pleased with the results we have been able to achieve during the COVID-19 pandemic. ....

Glasgow City , United Kingdom , United States , City Of , Bidhi Bhoma , Sukaina Virji , Paul Drayson , Tony Bourne , Euan Brown , Michael Macdonnell , Michael Norris , Richard Pye , Mary Jane Elliott , Davide Salvi , Oliver Jackson , Software Products , Market Of The London Stock Exchange , Milton Keynes University Hospital , University Of Oxford Phase , Sensyne Software Product , Bristol Myers Squibb , University Of Oxford , Discovery Sciences , Remuneration Committee , Peel Hunt , Milton Keynes University ,

Sensyne launches MagnifEye to analysis of lateral flow tests

Sensyne Health launches MagnifEye to automate the reading and Big Data analysis of lateral flow tests ....

Sensyne Health , Product News , Big Data , Drayson Phd , Sensyne Health Launches Magnifeye Smartphone Application To Automate The Reading And Big Data Analysis Of Lateral Flow Tests Using Deep Learning Ai Artificial Intelligence , Lateral Flow Testing , Covid 19 , ப்ராடக்ட் செய்தி , பெரியது தகவல்கள் , டிரேசன் ஃப்ட் , பக்கவாட்டு ஓட்டம் சோதனை ,

Sensyne Health plc: Sensyne Health Launches First Digital Health Product in the U.S.

Sensyne Health plc: Sensyne Health Launches First Digital Health Product in the U.S.
Sensyne Health plc (LSE: SENS) ( Sensyne or the Company or the Group ), the British Clinical AI technology company, today announces that it has launched GDm-Health, its remote monitoring solution for diabetes in pregnancy, in the U.S. with immediate effect.
Sensyne s sales and marketing partner for the U.S., Cognizant, is now offering the solution to U.S. health systems and health plans via its sales force. Virtual care services powered by GDm-Health will qualify for reimbursement under remote patient monitoring codes introduced by the Centers for Medicare and Medicaid Services (CMS) in 2020. ....

United States , United Kingdom , City Of , Bidhi Bhoma , Sukaina Virji , Euan Brown , Michael Norris , Mary Jane Elliott , Oliver Jackson , Davide Salvi , Derek Baird , Market Of The London Stock Exchange , Peel Hunt , Centers For Medicare , National Institute For Health , Jefferson Health , Company North American , Health At Jefferson , Sensyne Health , Digital Apps Library , Medicaid Services , International Diabetes Federation , Consilium Strategic Communications , British Clinical , North America , North American ,

Sensyne Health Launches First Digital Health Product in the U.S. – IT Business Net

Sensyne Health Launches First Digital Health Product in the U.S.
OXFORD, England–(BUSINESS WIRE)–Sensyne Health plc (LSE: SENS) (“Sensyne” or the “Company” or the “Group”), the British Clinical AI technology company, today announces that it has launched GDm-Health, its remote monitoring solution for diabetes in pregnancy, in the U.S. with immediate effect.
Sensyne’s sales and marketing partner for the U.S., Cognizant, is now offering the solution to U.S. health systems and health plans via its sales force. Virtual care services powered by GDm-Health will qualify for reimbursement under remote patient monitoring codes introduced by the Centers for Medicare and Medicaid Services (CMS) in 2020. ....

United States , United Kingdom , City Of , Bidhi Bhoma , Sukaina Virji , Euan Brown , Michael Norris , Mary Jane Elliott , Oliver Jackson , Davide Salvi , Derek Baird , Market Of The London Stock Exchange , Peel Hunt , Centers For Medicare , National Institute For Health , Jefferson Health , Company North American , Health At Jefferson , Sensyne Health , Digital Apps Library , Medicaid Services , International Diabetes Federation , Consilium Strategic Communications , British Clinical , North America , North American ,